- InvestInvestment SuiteExclusiveFeatures
- PlatformProduct SuiteFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnResourceInvesting GuideEvents
- Partner
- Support
Invest
Platform
Research
Market
Learn
Compare UTI Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 2.24 | 1.92 |
NAV | ₹286.38 | ₹38.82 |
Fund Started | 01 Aug 2005 | 25 Jun 2018 |
Fund Size | ₹1203.23 Cr | ₹5044.63 Cr |
Exit Load | Exit load of 1% if redeemed within 30 days. | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹500
₹100
Expense Ratio
2.24
1.92
NAV
₹286.38
₹38.82
Fund Started
01 Aug 2005
25 Jun 2018
Fund Size
₹1203.23 Cr
₹5044.63 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 1% if redeemed within 15 days.
Returns
1 Year | 45.36% | 49.14% |
3 Year | 22.09% | 25.86% |
5 Year | 27.58% | 30.25% |
1 Year
45.36%
49.14%
3 Year
22.09%
25.86%
5 Year
27.58%
30.25%
Holding Analysis
Equity | 97.88% | 97.27% |
Cash | 2.00% | 2.73% |
Equity
97.88%
97.27%
Cash
2.00%
2.73%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 10.73% |
Cipla Ltd. | 5.75% |
Ajanta Pharma Ltd. | 4.85% |
Dr. Reddy's Laboratories Ltd. | 4.70% |
Glenmark Pharmaceuticals Ltd. | 3.93% |
Gland Pharma Ltd. | 3.85% |
Apollo Hospitals Enterprise Ltd. | 3.41% |
Fortis Healthcare Ltd. | 3.35% |
Procter & Gamble Health Ltd. | 3.18% |
Divi's Laboratories Ltd. | 3.15% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 13.77% |
Dr. Reddy's Laboratories Ltd. | 8.48% |
Cipla Ltd. | 7.94% |
Aurobindo Pharma Ltd. | 5.04% |
Gland Pharma Ltd. | 4.38% |
Lupin Ltd. | 4.29% |
Alkem Laboratories Ltd. | 4.16% |
Zydus Lifesciences Ltd. | 3.10% |
Apollo Hospitals Enterprise Ltd. | 2.93% |
Biocon Ltd. | 2.39% |
Fund Manager
Name | Kamal Gada | Dharmesh Kakkad |
Start Date | 02 May 2022 | 23 Feb 2021 |
Name
Kamal Gada
Dharmesh Kakkad
Start Date
02 May 2022
23 Feb 2021
About Fund
Description | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 01 Aug 2005 | 25 Jun 2018 |
Description
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
01 Aug 2005
25 Jun 2018
